Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

826
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
826

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tools For Building Artificial Biological Nanostructures.

ACS nano·2026
Same author

Self-assembly of 3D Ternary Crystals Consisting of Biological and Synthetic Nanoparticles.

Biomacromolecules·2026
Same author

Nanochitin as Binder in Li-Ion Battery Anodes Enabling Aqueous Processing and Superior Solid Electrolyte Interphase.

ACS applied materials & interfaces·2026
Same author

Activity of ice-binding proteins can be markedly enhanced by protein tags.

Nanoscale·2026
Same author

Conductometric study of cellulose phosphate screening with divalent Ca2+ ions.

The Journal of chemical physics·2026
Same author

Engineering Chiroptical Interactions through Integrating Plasmonic Arrays with Cholesteric Nanocellulose.

Advanced materials (Deerfield Beach, Fla.)·2026

Related Experiment Video

Updated: Aug 15, 2025

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

7.7K

Engineered Protein Copolymers for Heparin Neutralization and Detection.

Qing Liu1,2, Ahmed Shaukat1, Zhuojun Meng2,3

  • 1Biohybrid Materials, Department of Bioproducts and Biosystems, Aalto University, Aalto00076, Finland.

Biomacromolecules
|January 4, 2023
PubMed
Summary
This summary is machine-generated.

Engineered protein nanoparticles effectively sequester heparin, acting as a potential antidote. This novel approach also enables sensitive heparin detection, offering a dual solution for anticoagulant management.

More Related Videos

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

8.1K
Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

7.4K

Related Experiment Videos

Last Updated: Aug 15, 2025

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

7.7K
Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

8.1K
Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

7.4K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Biochemistry

Background:

  • Heparin is a crucial anticoagulant, but its effects require reversal in clinical settings.
  • Existing methods for heparin neutralization and detection have limitations.
  • Protein cages inspire novel biomaterial designs for drug sequestration.

Purpose of the Study:

  • To develop protein-based nanoparticles for sequestering heparin.
  • To create a sensitive assay for heparin detection.
  • To evaluate the potential of engineered proteins for anticoagulant management.

Main Methods:

  • Design and synthesis of silk-like protein copolymers.
  • Formation of heparin-loaded nanoparticles (<200 nm).
  • Development of a competitive fluorescent switch-on assay for heparin detection.

Main Results:

  • Engineered protein copolymers formed well-defined nanoparticles encapsulating heparin.
  • The assay detected heparin with a limit of 0.01 IU mL-1 in plasma.
  • In vitro studies showed moderate cytocompatibility.

Conclusions:

  • Designed protein nanoparticles offer a promising strategy for heparin neutralization.
  • The developed assay provides sensitive heparin detection.
  • Further optimization is needed for in vivo applications of these protein copolymers.